Company: ARMP
Filing Date: 2025-04-28
Form Type: DEF 14A
Source: 0001104659-25-040273
Chunk: 41

Company: Armata Pharmaceuticals, Inc.
Filing Date: 2025-04-28
Form: DEF 14A
Chunk 41
---
claims such beneficial ownership except to the extent of their pecuniary interest therein, if any. (5) Consists of 168,298 shares of Common Stock that Ms. Kramer has the right to acquire from us within 60 days of April 17, 2025, pursuant to the exercise of stock options. (6) Consists of 188,681 shares of Common Stock that Dr. Patti has the right to acquire from us within 60 days of April 17, 2025, pursuant to the exercise of stock options. (7) Consists of 188,681 shares of Common Stock that Dr. Peterson has the right to acquire from us within 60 days of April 17, 2025, pursuant to the exercise of stock options. (8) Consists of (i) 188,681 shares of Common Stock that Dr. Schlesinger has the right to acquire from us within 60 days of April 17, 2025 pursuant to the exercise of stock options; (ii) 8,710,800 shares of Common Stock held by Innoviva, Inc.; (iii) 16,365,969 shares of Common Stock held by Innoviva Strategic Opportunities, LLC; (iv) 10,653,847 shares of Common Stock issuable upon exercise of the warrants to purchase Common Stock held by Innoviva Strategic Opportunities, LLC; and (v) 23,368,422 shares of Common Stock issuable to Innoviva Strategic Opportunities, LLC upon the conversion of a 27

certain convertible loan (including accrued interest as of April 17, 2025). Innoviva, Inc. and Innoviva Strategic Opportunities, LLC are entities with which Dr. Schlesinger is affiliated due to her position as a director of Innoviva, Inc. Dr. Schlesinger may be deemed to have shared voting and dispositive power over the shares beneficially owned by Innoviva, Inc. and Innoviva Strategic Opportunities, LLC, but disclaims such beneficial ownership except to the extent of their pecuniary interest therein, if any. (9) Consists of (i) 2,991 shares of Common Stock issued upon Restricted Stock Units that have vested, and (ii) 109,500 shares of Common Stock that Dr. Kyme has the right to acquire from us within 60 days of April 17, 2025 pursuant to the exercise of stock options. Does not include 7,500 shares of unvested Restricted Stock Units that do